Recent 8-K filings for EIKN

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 11, 2026 20:05 UTC earnings item 2.02item 7.01item 9.01

  Eikon Therapeutics Q1 2026 net loss $83M, cash $596M; three oncology programs advance

source · EIKN on sec.gov